AstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot.  AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison Muller